Ocugen IncEquity-NMS: OCGN
Equity-NMS: OCGN
$1.01
+0.06
(5 Oct)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$1.01
Open
$1.01
Today’s high
$1.03
Today’s low
$0.96
52W low
$0.34
52W high
$2.105
1Y
143.96%
5Y
-12.14%
EPS (TTM)
-0.18
Shares O/S
287.86M
Market cap
290.74M
Insights
OCGN price is below its 200 day moving average
OCGN is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Ocugen Inc

Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases.

The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. .


FAQs

Can I buy Ocugen Inc shares in India?
How to buy Ocugen Inc shares in India?
What is the share price of Ocugen Inc?
What is the Market Capitalization of Ocugen Inc?
What is the PE ratio of Ocugen Inc?
Is Ocugen Inc a good stock to buy?
In which sector / industry does Ocugen Inc operate?